Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation

Area of Science:

• Dermatology
• Regenerative Medicine
• Medical Devices

Background:

• Androgenetic alopecia (AGA) is a common cause of hair loss.
• Fractional laser therapy is an emerging device-based treatment for AGA.
• It utilizes controlled dermal injury to promote hair follicle regeneration.

Purpose of the Study:

• To evaluate the efficacy of fractional laser therapy in treating androgenetic alopecia.
• To compare different fractional laser modalities (ablative vs. non-ablative) for AGA treatment.
• To investigate the underlying mechanisms of laser-induced hair regeneration.

Main Methods:

• Utilized non-ablative erbium:glass (1550-1565 nm) and ablative (2940 nm, 10,600 nm) fractional laser platforms.
• Assessed outcomes including hair density, shaft diameter, and Wnt/β-catenin signaling.
• Conducted head-to-head comparisons of different laser wavelengths and types.

Main Results:

• Fractional laser therapy demonstrated clinically significant improvements in hair density and shaft diameter for both male and female AGA.
• Both ablative and non-ablative lasers activated hair follicle stem cells, upregulated Wnt/β-catenin signaling, enhanced vascularity, and modulated inflammation.
• The 1565 nm non-ablative fractional laser showed superior short-term improvements in hair density and terminal hair counts compared to other modalities.

Conclusions:

• Fractional laser therapy is an effective treatment for androgenetic alopecia.
• The 1565 nm non-ablative fractional laser is a promising option for short-term hair density improvement in AGA.
• Further research may elucidate long-term efficacy and optimal treatment protocols.